戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 licles on the face, neck, chest, and back by Propionibacterium acnes.
2 e immune response to the commensal bacterium Propionibacterium acnes.
3 antimicrobial activity against S. aureus and Propionibacterium acnes.
4 es, is caused by multiple factors, including Propionibacterium acnes.
5 46% vs 80%; 3) the most frequent isolate was Propionibacterium acnes (11/26) vs coagulase-negative St
6 iome at the strain level and genome level of Propionibacterium acnes, a dominant skin commensal, betw
7  mechanism by which S. aureus may commandeer Propionibacterium acnes, a key member of the human skin
8 In this issue, Kistowska et al. confirm that Propionibacterium acnes activates inflammasomes leading
9                                              Propionibacterium acnes and coagulase-negative Staphyloc
10 asts, 6 nonfermenters, and 1 isolate each of Propionibacterium acnes and coagulase-negative staphyloc
11 olleagues present strain-based resolution of Propionibacterium acnes and its association with the com
12  the presence of the Gram-positive bacterium Propionibacterium acnes and its potential association wi
13                      In vivo Th1 response to Propionibacterium acnes and lipopolysaccharide in IFN-ga
14 nished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
15 s associated with formation of resistance in Propionibacterium acnes and other bacteria, with clinica
16 ndependent growth, requiring helpers such as Propionibacterium acnes and Prevotella intermedia for st
17              Low virulence organisms such as Propionibacterium acnes are the most common culprit orga
18                     We report a patient with Propionibacterium acnes bacteremia and late prosthetic v
19                                              Propionibacterium acnes, causative agent of chronic pros
20 n are compounded by increasing resistance of Propionibacterium acnes clinical isolates.
21 Bradyrhizobium, Anaerococcus, Peptoniphilus, Propionibacterium acnes, Dorea, and Ruminococcus and red
22 rial pathogens including Bacillus anthracis, Propionibacterium acnes, Enterococcus faecalis, and both
23 resulting from the immune response targeting Propionibacterium acnes has a significant role in its pa
24                                              Propionibacterium acnes has been identified as a signifi
25                 The microaerophylic organism Propionibacterium acnes has shown consistent association
26 e primed 12 days in advance with heat-killed Propionibacterium acnes, IL-18BP-Fc prevents LPS-induced
27 ase-negative staphylococci in 6.0% (27/448), Propionibacterium acnes in 4.7% (21/448), and Pseudomona
28 ica charantia Linn. var. abbreviata Ser.) on Propionibacterium acnes-induced inflammation and to iden
29 us studies showed that TLR9 and TLR2 mediate Propionibacterium acnes-induced sensitization to lipopol
30                      Agak et al. report that Propionibacterium acnes induces IL-17 expression in peri
31                                              Propionibacterium acnes induction of IL-1 cytokines thro
32                                              Propionibacterium acnes induction of inflammatory respon
33  have been sensitized to endotoxin damage by Propionibacterium acnes infection.
34                                              Propionibacterium acnes is a critical component in the p
35                                              Propionibacterium acnes is a key pathogen involved in th
36                                              Propionibacterium acnes is a key therapeutic target in a
37                                              Propionibacterium acnes is a known cause of postneurosur
38                                              Propionibacterium acnes is a major etiological factor of
39                  The Gram-positive bacterium Propionibacterium acnes is a member of the normal human
40                                              Propionibacterium acnes is a skin commensal bacterium th
41                                              Propionibacterium acnes is a well-known cause of delayed
42                                              Propionibacterium acnes is also associated with inflamma
43             The opportunistic human pathogen Propionibacterium acnes is composed of a number of disti
44                                              Propionibacterium acnes is increasingly recognized as an
45                Cutibacterium acnes (formerly Propionibacterium acnes) is recognized as a pathogen in
46                                              Propionibacterium acnes isolates usually have relatively
47  1), Propionibacterium species (n = 15), and Propionibacterium acnes (n = 19) isolates; all of these
48 stigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem
49     Mycothiol production was not detected in Propionibacterium acnes or in representative species of
50 S (20 microg/mouse) 7 days after heat-killed Propionibacterium acnes (P. acnes) injection into wild-t
51 monstrate that fermentation of glycerol with Propionibacterium acnes (P. acnes), a skin commensal bac
52 ne treatment as a natural antibiotic against Propionibacterium acnes (P. acnes), which promotes folli
53 e investigated the roles of TLR2 and TLR4 in Propionibacterium acnes (P. acnes)-primed, LPS-induced l
54      In patients with AgP, Actinomyces oris, Propionibacterium acnes, P. aeruginosa, Staphylococcus a
55  relative abundances of propionibacteria and Propionibacterium acnes phage in healthy skin.
56 overed, including Escherichia coli phage T3, Propionibacterium acnes phage PA6, and Streptococcus mit
57 on of early childhood acne, the emergence of Propionibacterium acnes resistance, and the rare but ser
58 teen of the species or phylotypes, including Propionibacterium acnes, Staphylococcus spp., and the op
59  observed the decline of an early-colonizing Propionibacterium acnes strain similar to SK137 and the
60 ny countries reporting that more than 50% of Propionibacterium acnes strains are resistant to topical
61 es of the human skin microbiome suggest that Propionibacterium acnes strains may contribute different
62 ddress the emergence of antibiotic-resistant Propionibacterium acnes strains.
63  Prevotella oris, Staphylococcus aureus, and Propionibacterium acnes strains.
64 s-wide comparative analysis of 90 genomes of Propionibacterium acnes that represent the known diversi
65 rect antimicrobial activity in vitro against Propionibacterium acnes, the bacterium linked to the pat
66 nflammation is due in part to the ability of Propionibacterium acnes to activate TLR2.
67                    C57BL/6 mice treated with Propionibacterium acnes to elicit high levels of macroph
68 ntial evidence that links the skin bacterium Propionibacterium acnes to the condition.
69 nas and Peptoniphilus species (type IV), and Propionibacterium acnes (type V).
70       The culture supernatant of a strain of Propionibacterium acnes was investigated for its phospho
71                                              Propionibacterium acnes was the commonest species detect
72 ct to sequence multiple clinical isolates of Propionibacterium acnes, we have produced a draft genome
73 teria such as Staphylococcus epidermidis and Propionibacterium acnes, were identified in bacteriologi
74 ulture showed antimicrobial activity against Propionibacterium acnes, whereas the enhanced antimicrob
75 cular hyperkeratinization, and the action of Propionibacterium acnes within the follicle.
76 t contributes to the pathogenesis of acne is Propionibacterium acnes; yet, the molecular mechanism by

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。